We are developing dendritic cell -
based vaccines targeting telomerase, a protein expressed in over 95 percent of cancers and rarely found in normal adult cells.
Not exact matches
Researchers at MedImmune, a Maryland -
based biotech company, and at Washington University in St. Louis whipped up two separate
vaccine formulations in the hope that at least one would successfully
target an «adhesion» molecule called Filamentous H, or FimH, present on E. coli.
The Pasteur team says the finding could lead to the development of
vaccines based on CD26 inhibitors or an antibody
targeting either the V3 loop or CD26.
Childhood
vaccines are recommended worldwide,
based on their protective effect against the
targeted diseases.
To be most effective, DNA
vaccines need to be
based on the genes of the viruses present in the
target population, so regular genetic diversity monitoring is essential, Dukhovlinova says.
These same models are used to develop new anti-cancer
vaccines based on long peptide or DNA vaccination
targeting the antigen to antigen presenting cells.
«Each patient is different, so we're developing a personalized
vaccine based on specific
targets we identify on a patient's tumor,» Overman says.
As a part of VIOLIN, we have developed Vaxign, the first web -
based publically available
vaccine target design tool
based on bioinformatics analysis of genome sequences using the strategy of reverse vaccinology.
The paper reports that it could potentially form the
base for a new universal influenza
vaccine that could
target all strains of the virus.
A key program of VIOLIN is Vaxign, the first web -
based publically available
vaccine target design tool
based on bioinformatics analysis of genome sequences using the strategy of reverse vaccinology.
Such antibodies are expected to reduce the efficacy of
vaccines based on common human serotypes of adenovirus in a human
target population.
«This loss - of - HLA mechanism suggests that, when designing
vaccines and cell -
based therapies, we need to
target antigens that are presented to the immune system,» says Swanton.